Low-dose oral methotrexate versus oral prednisolone for eruptive lichen planus: A randomized comparative pilot study
Sri Lanka Journal of Dermatology · 08.06.2026 · 25 (1) · 24-32
DOI: 10.4038/sljd.v25i1.417 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sri Lanka Journal of Dermatology, online erschienen am 08.06.2026. Verfasst von Kalani Samarasinghe und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Eruptive lichen planus is a rare and severe variant characterised by widespread cutaneous involvement, intense pruritus, and frequent relapses. Systemic corticosteroids are commonly used but are associated with significant adverse effects and relapse. Low-dose methotrexate has emerged as a potential alternative.
Objectives
To compare the efficacy, safety, and relapse rates of oral prednisolone and oral low-dose methotrexate in eruptive lichen planus.
Methods
A randomized single-blind comparative pilot study was conducted among 30 patients attending the dermatology clinic at the National Hospital of Sri Lanka. Participants were allocated using computer-generated randomisation with allocation concealment via sealed envelopes. Patients received either oral prednisolone (0.5 mg/kg/day) or methotrexate (10–15 mg/week) for 16 weeks. Outcomes were assessed using the pruritus Numerical Rating Scale (0–10) and percentage body surface area (BSA) involvement. Intention-to-treat analysis was performed.
Results
Early partial response at 4 weeks was higher in the prednisolone group (66.7% vs 26.7%; p=0.028). At 16 weeks, complete response rates were comparable (86.7% vs 66.6%; p>0.05). Relapse at 6 months was higher in the steroid group (26.7% vs 6.7%). Adverse events were comparable.
Conclusions
Prednisolone provides faster disease control, while methotrexate may reduce relapse. Methotrexate is a safe and effective alternative.
Zitieren
APA
Samarasinghe, K., & Gunasekera, C. (2026). Low-dose oral methotrexate versus oral prednisolone for eruptive lichen planus: A randomized comparative pilot study. Sri Lanka Journal of Dermatology, 25(1), 24-32. https://doi.org/10.4038/sljd.v25i1.417
Vancouver
Samarasinghe K, Gunasekera C. Low-dose oral methotrexate versus oral prednisolone for eruptive lichen planus: A randomized comparative pilot study. Sri Lanka Journal of Dermatology. 2026;25(1):24-32. doi:10.4038/sljd.v25i1.417
BibTeX
@article{Samarasinghe2026,
author = {Samarasinghe, Kalani and Gunasekera, Chalukya},
title = {Low-dose oral methotrexate versus oral prednisolone for eruptive lichen planus: A randomized comparative pilot study},
journal = {Sri Lanka Journal of Dermatology},
year = {2026},
volume = {25},
number = {1},
pages = {24--32},
doi = {10.4038/sljd.v25i1.417}
}
EUVIMED